Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Respiratory Inhaler Devices Market from 2024 to 2025?
The market for respiratory inhaler devices has experienced substantial growth in the past few years. Its projected to increase from $41.35 billion in 2024 to $44.33 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.2%. This historical growth trend has been driven by factors such as increased smoking prevalence, a rise in allergic disorders, innovations in the pharmaceutical sector, and an aging population.
What Is the Projected Market Size of the Respiratory Inhaler Devices Market?
Expectations are high for a robust growth in the respiratory inhaler devices market in the coming few years, with predictions forecasting a growth to $59.55 billion by 2029 – this denotes a compound annual growth rate (CAGR) of 7.7%. This anticipated surge in the prediction period can be attributed to factors such as concerns over air quality, integration of digital health, regulatory focus on inhaler safety, and personalized treatment methods. The forecast period is also set to witness major trends such as the miniaturization of inhaler devices, sustainability and eco-friendly inhalers, a shift towards home-based care, and technological advancements.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13014&type=smp
Who are the Major Competitors in the Respiratory Inhaler Devices Market Outlook?
Major companies operating in the respiratory inhaler devices market are Merck & Co. Inc., Novartis AG, AstraZeneca PLC, Gerresheimer AG, GlaxoSmithKline PLC, 3M, Boehringer Ingelheim International GmbH, Koninklijke Philips N.V., Viatris Inc., Teva Pharmaceutical Industries Ltd., Catalent Inc., Perrigo Company PLC, AptarGroup Inc., Recipharm AB, Chiesi Farmaceutici S.p.A., Cipla Limited, Hikma Pharmaceuticals PLC, Zydus Lifesciences Limited, Lupin Limited, Glenmark Pharmaceuticals Ltd., Orion Corporation, Sumitomo Pharma America Inc., Beximco Pharmaceuticals Ltd., Hovione Limited, Vectura Group Limited, H&T Presspart Manufacturing Ltd., Pari Medical Holding GmbH, OMRON Healthcare Europe B.V., Medisol Lifescience Pvt. Ltd., Consort Medical plc.
What Is Fueling Growth in the Respiratory Inhaler Devices Market?
The escalation in respiratory illnesses is anticipated to spur the respiratory inhaler devices market’s expansion. These disorders, affecting the lungs and respiratory system, result in breathing challenges and hindered lung function. Respiratory inhaler devices, delivering medications straight to the lungs, offer fast and focused alleviation for many respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), respiratory syncytial virus infection and other such disorders. For instance, the Centers for Disease Control and Prevention, a US-based national public health organization, advised in March 2023 that the United States experienced an increase from 7,874 tuberculosis (TB) cases in 2021 to 8,300 cases in 2022. Consequently, the escalating prevalence of respiratory diseases is driving the respiratory inhaler devices market’s growth.
Respiratory Inhaler Devices Market Driver: Increase in Smoking Rates Fuels the Demand for Respiratory Inhaler Devices Market
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=13014&type=smp
Which Respiratory Inhaler Devices Market Segments Are Growing the Fastest?
The respiratory inhaler devices market covered in this report is segmented –
1) By Product: Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers
2) By Technology: Manually Operated Inhaler Devices, Digitally Operated Inhaler Devices
3) By Disease Indication: Asthma, Chronic Obstructive Pulmonary Disease, Pulmonary Arterial Hypertension, Other Indications
4) By End User: Hospitals And Clinics, Respiratory Care Centers, Other End Users
Subsegments:
1) By Dry Powder Inhalers: Single-Dose Inhalers, Multi-Dose Inhalers
2) By Metered Dose Inhalers: CFC-Based MDIs, HFA-Based MDIs
3) By Nebulizers: Jet Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers
Which Industry Trends Are Shaping the Future of the Respiratory Inhaler Devices Market?
Leading firms in the respiratory inhaler devices market are embracing cutting-edge technologies like metered dosage inhalers to maintain their market dominance. A metered dosage inhaler (MDI) is a handy aerosol contrivance that administers an exact medication dose to the lungs in mist or inhalable spray form. Take the example of AptarGroup Inc., a USA-based manufacturer of consumer dispensing packaging and drug delivery devices, who introduced HeroTracker Sense in February 2022. This state-of-the-art digital respiratory health tool transforms a conventional metered dosage inhaler (pMDI) into a smart, interconnected medical gadget. HeroTracker Sense is designed to keep an eye on patients’ MDI usage and encourage greater compliance with their prescribed treatment, ultimately enhancing the quality of life for patients globally dealing with chronic respiratory illnesses like asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and other respiratory complications caused by COVID-19. The HeroTracker Sense supplies imperative analytics and patient insights on education, induction, and performance to healthcare practitioners via the Aptar Pharma Cohero Health BreatheSmart Connect portal.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/respiratory-inhaler-devices-global-market-report
Which Countries Are Leading the Respiratory Inhaler Devices Market?
North America was the largest region in the respiratory inhaler devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in respiratory inhaler devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13014
This Report Delivers Insight On:
1. How big is the respiratory inhaler devices market, and how is it changing globally?
2. Who are the major companies in the respiratory inhaler devices market, and how are they performing?
3. What are the key opportunities and risks in the respiratory inhaler devices market right now?
4. Which products or customer segments are growing the most in the respiratory inhaler devices market?
5. What factors are helping or slowing down the growth of the respiratory inhaler devices market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model